Literature DB >> 2552044

Supratentorial anaplastic gliomas in adults. The prognostic importance of extent of resection and prior low-grade glioma.

M J Winger1, D R Macdonald, J G Cairncross.   

Abstract

A retrospective analysis is presented of factors affecting the length of survival of 285 consecutive adults with newly diagnosed biopsy-proven supratentorial anaplastic glioma (188 cases of glioblastoma multiforme, 76 of anaplastic astrocytoma, 11 of anaplastic mixed glioma, and 10 of anaplastic oligodendroglioma) treated at a regional cancer center from July, 1982, through December, 1987. The approach to initial therapy included maximum feasible resection and radiotherapy. The median survival time for all patients was 35 weeks. Multivariate analysis demonstrated that age, duration of symptoms, preirradiation performance status, tumor histology, accessibility to resection, extent of resection, radiotherapy, and prior low-grade glioma were significant independent variables influencing survival. The prognostic importance of age, duration of symptoms, performance status, and tumor histology are already recognized, but three "new" findings are reported. First, patients with anaplastic oligodendroglioma had the longest median survival time (278 weeks). Second, corrected for accessibility and all other variables, patients with gross total resection lived longer than those with partial resection, and patients with any degree of resection lived longer than those who underwent only a biopsy procedure. Third, patients with anaplastic glioma in whom there was a prior history of low-grade glioma lived significantly longer after the diagnosis of anaplastic glioma than did patients in whom the anaplastic glioma apparently arose de novo.

Entities:  

Mesh:

Year:  1989        PMID: 2552044     DOI: 10.3171/jns.1989.71.4.0487

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  66 in total

Review 1.  The role of image-guided technology in the surgical planning and resection of gliomas.

Authors:  G H Barnett
Journal:  J Neurooncol       Date:  1999-05       Impact factor: 4.130

2.  Extent of resection in malignant gliomas: a critical summary.

Authors:  R Sawaya
Journal:  J Neurooncol       Date:  1999-05       Impact factor: 4.130

3.  Should all patients with malignant astrocytoma have postoperative radiotherapy?

Authors:  A Snijders-Keilholz; J H Voormolen; J Hermans; G W Padberg; J Davelaar; J W Leer
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

Review 4.  Paediatric and adult malignant glioma: close relatives or distant cousins?

Authors:  Chris Jones; Lara Perryman; Darren Hargrave
Journal:  Nat Rev Clin Oncol       Date:  2012-05-29       Impact factor: 66.675

5.  Fluorescent nanoparticle uptake for brain tumor visualization.

Authors:  Rachel Tréhin; Jose-Luiz Figueiredo; Mikael J Pittet; Ralph Weissleder; Lee Josephson; Umar Mahmood
Journal:  Neoplasia       Date:  2006-04       Impact factor: 5.715

6.  Prognostic factors for survival in 676 consecutive patients with newly diagnosed primary glioblastoma.

Authors:  Graziella Filippini; Chiara Falcone; Amerigo Boiardi; Giovanni Broggi; Maria G Bruzzone; Dario Caldiroli; Rita Farina; Mariangela Farinotti; Laura Fariselli; Gaetano Finocchiaro; Sergio Giombini; Bianca Pollo; Mario Savoiardo; Carlo L Solero; Maria G Valsecchi
Journal:  Neuro Oncol       Date:  2007-11-09       Impact factor: 12.300

7.  Evaluation of MR markers that predict survival in patients with newly diagnosed GBM prior to adjuvant therapy.

Authors:  Suja Saraswathy; Forrest W Crawford; Kathleen R Lamborn; Andrea Pirzkall; Susan Chang; Soonmee Cha; Sarah J Nelson
Journal:  J Neurooncol       Date:  2008-09-23       Impact factor: 4.130

Review 8.  Brain tumors.

Authors:  K L Black; J C Mazziotta; D P Becker
Journal:  West J Med       Date:  1991-02

Review 9.  Pathology and molecular genetics of oligodendroglial tumors.

Authors:  Christian Hartmann; Wolf Mueller; Andreas von Deimling
Journal:  J Mol Med (Berl)       Date:  2004-10       Impact factor: 4.599

10.  Validation of the Medical Research Council and a newly developed prognostic index in patients with malignant glioma: how useful are prognostic indices in routine clinical practice?

Authors:  Fadime Akman; Rachel A Cooper; Mehmet Sen; Yildiray Tanriver; Süleyman Kentli
Journal:  J Neurooncol       Date:  2002-08       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.